Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Diabetic Neuropathies; Peripheral Nervous System Diseases Phase 2 ClinicalTrials
Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Neuropathies Phase 1/Phase 2 ClinicalTrials
CONTENTS